FOXM1 and ovarian carcinoma: Olaparib activated the FOXM1 pathway as an adaptive cellular response to DNA damage, and FOXM1 inhibition enhanced sensitivity to PARPi in ES-2 and OVCA420 ovarian cancer cells 9.